Home/Filings/4/0001209191-21-036585
4//SEC Filing

Maetzel Andreas 4

Accession 0001209191-21-036585

CIK 0001348911other

Filed

May 27, 8:00 PM ET

Accepted

May 28, 5:20 PM ET

Size

5.8 KB

Accession

0001209191-21-036585

Insider Transaction Report

Form 4
Period: 2021-05-26
Maetzel Andreas
Senior Vice President Medical
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2021-05-26+25,00025,000 total
    Exercise: $25.95Exp: 2031-05-25Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The option vests over a 4 year period: 1/48th on June 26, 2021, after which 1/48th of the total shares vest monthly, subject to continued service through each vesting date.

Issuer

KalVista Pharmaceuticals, Inc.

CIK 0001348911

Entity typeother

Related Parties

1
  • filerCIK 0001576103

Filing Metadata

Form type
4
Filed
May 27, 8:00 PM ET
Accepted
May 28, 5:20 PM ET
Size
5.8 KB